89bio (NASDAQ:ETNB – Get Rating) had its price target lowered by research analysts at SVB Leerink from $62.00 to $50.00 in a research report issued to clients and investors on Friday, Benzinga reports. The brokerage presently has an “outperform” rating on the stock. A number of other brokerages have also weighed in on ETNB. Zacks […]